Your browser doesn't support javascript.
loading
Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause.
Zhou, Junhua; Azizan, Elena A B; Cabrera, Claudia P; Fernandes-Rosa, Fabio L; Boulkroun, Sheerazed; Argentesi, Giulia; Cottrell, Emily; Amar, Laurence; Wu, Xilin; O'Toole, Sam; Goodchild, Emily; Marker, Alison; Senanayake, Russell; Garg, Sumedha; Åkerström, Tobias; Backman, Samuel; Jordan, Suzanne; Polubothu, Satyamaanasa; Berney, Daniel M; Gluck, Anna; Lines, Kate E; Thakker, Rajesh V; Tuthill, Antoinette; Joyce, Caroline; Kaski, Juan Pablo; Karet Frankl, Fiona E; Metherell, Lou A; Teo, Ada E D; Gurnell, Mark; Parvanta, Laila; Drake, William M; Wozniak, Eva; Klinzing, David; Kuan, Jyn Ling; Tiang, Zenia; Gomez Sanchez, Celso E; Hellman, Per; Foo, Roger S Y; Mein, Charles A; Kinsler, Veronica A; Björklund, Peyman; Storr, Helen L; Zennaro, Maria-Christina; Brown, Morris J.
Afiliação
  • Zhou J; Endocrine Hypertension, Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, UK.
  • Azizan EAB; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Cabrera CP; Endocrine Hypertension, Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, UK. elena.azizan@ukm.edu.my.
  • Fernandes-Rosa FL; Department of Medicine, The National University of Malaysia (UKM) Medical Centre, Kuala Lumpur, Malaysia. elena.azizan@ukm.edu.my.
  • Boulkroun S; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Argentesi G; Centre for Translational Bioinformatics, William Harvey Research Institute, Queen Mary University of London, London, UK.
  • Cottrell E; Université de Paris, PARCC, Inserm, Paris, France.
  • Amar L; Université de Paris, PARCC, Inserm, Paris, France.
  • Wu X; Endocrine Hypertension, Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, UK.
  • O'Toole S; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Goodchild E; Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK.
  • Marker A; Université de Paris, PARCC, Inserm, Paris, France.
  • Senanayake R; Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Unité Hypertension Artérielle, Paris, France.
  • Garg S; Endocrine Hypertension, Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, UK.
  • Åkerström T; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Backman S; Endocrine Hypertension, Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, UK.
  • Jordan S; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Polubothu S; Endocrine Hypertension, Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, UK.
  • Berney DM; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Gluck A; Department of Histopathology, Addenbrooke's Hospital, Cambridge, UK.
  • Lines KE; Metabolic Research Laboratories, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, UK.
  • Thakker RV; Endocrine Hypertension, Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, UK.
  • Tuthill A; NIHR Barts Cardiovascular Biomedical Research Centre, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Joyce C; Metabolic Research Laboratories, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, UK.
  • Kaski JP; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Karet Frankl FE; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Metherell LA; Cellular Pathology Department, Royal London Hospital, London, UK.
  • Teo AED; Genetics and Genomic Medicine, University College London Great Ormond Street Institute of Child Health, London, UK.
  • Gurnell M; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Parvanta L; Academic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Drake WM; Academic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Wozniak E; Academic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Klinzing D; Department of Endocrinology and Diabetes, Cork University Hospital, Cork, Ireland.
  • Kuan JL; Clinical Biochemistry, Cork University Hospital, Cork, Ireland.
  • Tiang Z; Centre for Inherited Cardiovascular Diseases, Great Ormond Street Hospital and University College London Institute of Cardiovascular Science, London, UK.
  • Gomez Sanchez CE; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.
  • Hellman P; Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK.
  • Foo RSY; Dept of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Mein CA; Metabolic Research Laboratories, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, UK.
  • Kinsler VA; Department of Surgery, St Bartholomew's Hospital, London, UK.
  • Björklund P; Department of Endocrinology, St Bartholomew's Hospital, London, UK.
  • Storr HL; Barts and London Genome Centre, School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK.
  • Zennaro MC; Cardiovascular Disease Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Brown MJ; Cardiovascular Disease Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Nat Genet ; 53(9): 1360-1372, 2021 09.
Article em En | MEDLINE | ID: mdl-34385710
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias do Córtex Suprarrenal / Adenoma Adrenocortical / Subunidades alfa de Proteínas de Ligação ao GTP / Aldosterona / Beta Catenina Limite: Adolescent / Adult / Female / Humans / Male / Middle aged / Pregnancy Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias do Córtex Suprarrenal / Adenoma Adrenocortical / Subunidades alfa de Proteínas de Ligação ao GTP / Aldosterona / Beta Catenina Limite: Adolescent / Adult / Female / Humans / Male / Middle aged / Pregnancy Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido